China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.43 CNY -3.68% Market Closed
Market Cap: 15.8B CNY
Have any thoughts about
China Resources Boya Bio pharmaceutical Group Co Ltd?
Write Note

Relative Value

The Relative Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 32.41 CNY. Compared to the current market price of 31.43 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
32.41 CNY
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
53
Median 3Y
6.3
Median 5Y
6
Industry
7.7
Forward
8.3
vs History
1
vs Industry
2
Median 3Y
42.2
Median 5Y
43.1
Industry
22.7
Forward
27.9
vs History
11
vs Industry
6
Median 3Y
24.7
Median 5Y
23.1
Industry
21.6
vs History
4
vs Industry
5
Median 3Y
30.6
Median 5Y
30.6
Industry
25.2
vs History
84
vs Industry
38
Median 3Y
2.3
Median 5Y
2.5
Industry
2.5
vs History
7
vs Industry
53
Median 3Y
4.6
Median 5Y
4.8
Industry
7.7
Forward
5.5
vs History
28
vs Industry
40
Median 3Y
8.5
Median 5Y
8.5
Industry
9
vs History
3
vs Industry
2
Median 3Y
28.5
Median 5Y
29.8
Industry
4.2
Forward
13.6
vs History
3
vs Industry
2
Median 3Y
28.5
Median 5Y
29.8
Industry
4.1
Forward
16.4
vs History
12
vs Industry
7
Median 3Y
17.6
Median 5Y
17.6
Industry
5.7
vs History
6
vs Industry
6
Median 3Y
21.2
Median 5Y
19.8
Industry
3.6
vs History
39
vs Industry
31
Median 3Y
4.3
Median 5Y
4
Industry
4.6

Multiples Across Competitors

Competitors Multiples
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
15.8B CNY 9.3 85.2 59.3 59.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average P/E: 187.8
85.2
208%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average EV/EBITDA: 23.2
59.3
85%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average EV/EBIT: 27.8
59.3
44%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top